Prestige Wealth Management Group LLC Eli Lilly & CO Transaction History

Prestige Wealth Management Group LLC

$443 Million
Q1 2024

A detailed history of Prestige Wealth Management Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 553 shares of LLY stock, worth $505,757. This represents 0.1% of its overall portfolio holdings.

Number of Shares

553

Previous 554 0.18%

Holding current value

$505,757

Previous $322,000 33.54%

% of portfolio

0.1%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $592 - $792	-1 Reduced 0.18%	553 $430,000
Q4 2023 Apr 26, 2024	SELL	$525.19 - $619.13 $28,885 - $34,052	-55 Reduced 9.03%	554 $322,000
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $28,885 - $34,052	-55 Reduced 9.03%	554 $322,000
Q3 2023 Apr 26, 2024	BUY	$434.7 - $599.3 $869 - $1,198	2 Added 0.33%	609 $327,000
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $869 - $1,198	2 Added 0.33%	609 $327,000

Q2 2023 Apr 26, 2024	SELL	$350.74 - $468.98 $774,083 - $1.04 Million	-2,207 Reduced 78.43%	607 $284,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $774,083 - $1.04 Million	-2,207 Reduced 78.43%	607 $284,000
Q1 2023 Apr 26, 2024	BUY	$310.63 - $364.82 $702,334 - $824,858	2,261 Added 408.86%	2,814 $966,000
Q1 2023 May 16, 2023	BUY	$310.63 - $364.82 $689,909 - $810,265	2,221 Added 374.54%	2,814 $966,000
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $620,913 - $723,487	-1,931 Reduced 76.51%	593 $216,000
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $56,924 - $64,871	192 Added 8.23%	2,524 $816,000
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $7,246 - $8,509	-26 Reduced 1.1%	2,332 $756,000
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $416,105 - $517,113	1,773 Added 303.08%	2,358 $675,000
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $13,266 - $16,463	-59 Reduced 9.16%	585 $162,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $36,342 - $44,724	164 Added 34.17%	644 $149,000
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $33,221 - $42,971	-184 Reduced 27.71%	480 $110,000
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $4,436 - $5,743	27 Added 4.24%	664 $124,000
Q4 2020 Feb 17, 2021	SELL	$130.46 - $172.63 $11,089 - $14,673	-85 Reduced 11.77%	637 $108,000
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $10,966 - $12,684	75 Added 11.59%	722 $107,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $5,593 - $6,731	41 Added 6.77%	647 $106,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $32,738 - $40,521	275 Added 83.08%	606 $84,000
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $962 - $1,191	-9 Reduced 2.65%	331 $44,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $3,096 - $3,368	29 Added 9.32%	340 $38,000
Q1 2019 Aug 16, 2019	SELL	$111.31 - $131.02 $26,714 - $31,444	-240 Reduced 43.56%	311 $40,000
Q4 2018 Apr 16, 2019	BUY	$105.9 - $118.64 $58,350 - $65,370	551 New	551 $64,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Eli Lilly & CO Transaction History